Ignite Creation Date:
2024-05-05 @ 5:15 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412646
Status:
COMPLETED
Last Update Posted:
2010-04-28
First Post:
2006-12-15
Brief Title:
TMC125-C203 Phase II Randomized Patients Are Assigned Different Treatments Based on Chance Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland